SCILEX HOLDING CO
SCLXNASDAQTrading Snapshot
- Day Range
- $0.53 β $0.60
- 52-Week Range
- $0.54 β $27.00
- Volume (shares)
- 198,279
- Avg Volume (shares)
- β
- Shares Outstanding
- 8.5M
- Next Earnings
- 2026-12-02
Fundamentals Snapshot
- Annual Revenue
- $30M
- Last Q Revenue
- $8M
- P/E Ratio
- β
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-48.45
- Dividend Yield
- β
- Dilution (1yr)
- β0.4%
SCILEX HOLDING CO
SCLXAbout SCILEX HOLDING CO
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
βLatest News & Updates

Datavault AI Stock Crashes β Financials Cannot Be Trusted: What You Need to Know
Shares of Datavault AI Inc. (NASDAQ:DVLT) fell nearly 40% after the company told investors to stop relying on financial results stretching back to the third quarter of 2025.

Head to Head Review: Sanofi (NASDAQ:SNY) vs. Scilex (NASDAQ:SCLX)
Sanofi (NASDAQ: SNY - Get Free Report) and Scilex (NASDAQ: SCLX - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analy

Iterum Therapeutics (NASDAQ:ITRM) vs. Scilex (NASDAQ:SCLX) Critical Review
Scilex (NASDAQ: SCLX - Get Free Report) and Iterum Therapeutics (NASDAQ: ITRM - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the

Head to Head Survey: Scilex (NASDAQ:SCLX) versus Incannex Healthcare (NASDAQ:IXHL)
Scilex (NASDAQ: SCLX - Get Free Report) and Incannex Healthcare (NASDAQ: IXHL - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the str